Survey of the Landscape of Society Practice Guidelines for Genetic Testing of Neurodevelopmental Disorders.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 39319594.
- Also identified by DOI 10.1002/ana.27045 and PMC identifier 11496025.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Genetic testing of patients with neurodevelopmental disabilities (NDDs) is critical for diagnosis, medical management, and access to precision therapies. Because genetic testing approaches evolve rapidly, professional society practice guidelines serve an essential role in guiding clinical care; however, several challenges exist regarding the creation and equitable implementation of these guidelines. In this scoping review, we assessed the current state of United States professional societies' guidelines pertaining to genetic testing for unexplained global developmental delay, intellectual disability, autism spectrum disorder, and cerebral palsy. We describe several identified shortcomings and argue the need for a unified, frequently updated, and easily-accessible cross-specialty society guideline. ANN NEUROL 2024;96:900-913.
Medical subject headings
- Neurodevelopmental Disorders
- Genetic Testing
- Practice Guidelines as Topic